Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cannara Biotech Inc. V.LOVE

Alternate Symbol(s):  LOVFF

Healthcare Cannabis
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:LOVE)

Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market Expansion

PR Newswire January 30, 2024

Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")

PR Newswire January 8, 2024

Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024

PR Newswire December 13, 2023

Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023

PR Newswire December 11, 2023

Cannara reports record growth and profitability in Q4 2023

Jonathon Brown December 7, 2023

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues

PR Newswire December 7, 2023

Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million

PR Newswire July 27, 2023

Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII

Newsfile May 23, 2023

Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference

PR Newswire May 11, 2023
View More News ››

Opinion & Analysis (TSXV:LOVE)

Positioned for Long-Term Growth: The Cannabis Co. that’s Driving Strong Revenue Results

Dave Jackson June 29, 2021
View More Opinion ››

Bullboard Posts (TSXV:LOVE)

BMO 50m loan

Cannara announced today that it has closed on a $50M credit facility led by BMO Commercial Banking.  The credit facility...
Flymore123 - April 8, 2024

Belle trouvaulle... Look that...

https://technical420.com/cannabis-article/cannara-biotech-a-deep-dive/
realistic25 - March 9, 2024

RE:RE:RE:35 million gross sales last year.....

Hi Nick, I have been following Cannara over the past year and have been investing. Great story and look forward to a long-term...
cklv0 - February 29, 2024

RE:RE:35 million gross sales last year.....

Hi, Nick the CFO here at Cannara, What exactly is it that we dont know what we are doing? id be glad to provide further insight but we...
NIkoDank - January 16, 2024

RE:35 million gross sales last year.....

Further to that, the management  team and growers have no clue what they're doing! They have a poor reputation amongst consumers...
AvInvestor - January 14, 2024

Cannara Biotech Inc. reports Q2 2023 Financial Results

Six-month net revenues of $23.4 million, a 67% increase compared to first half 2022 Delivered its eighth consecutive quarter of...
Betteryear2 - April 24, 2023
View more Bullboard ››

Royalties Inc.

Royalties Inc.

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ...
View More »